Укр
Eng
On March 13, 2015 on the web-site of the Ministry of Healthcare of Ukraine the draft of the Regulation of the Cabinet of Ministers of Ukraine was published, which is consider to change the Regulation of the Cabinet of Ministers of Ukraine “On reference pricing for medicinal products and medical devices procured by the state and local budgets”, dated 02.07.2014 N 240, in the aspect of the declaring currency of wholesale and selling price (hereafter as the Draft of Regulation).
In particular, in the case of adoption of the Draft of Regulation the changes of wholesale and selling prices for medicinal products and medical devices of foreign manufacture will be declared in national and foreign currency, and products of domestic manufacture, same as before, in national currency. At that, the price declaring for medicinal products inclusive of arithmetic mean value is still.
The healthcare facilities and organizations, financed by the state and local budgets, may purchase medicinal products and medical devices at prices, which are not exceed the level of declared prices in national or foreign currency inclusive of duty, VAT and maximum supply / sales and trade (selling) markups.
The Draft of Regulation shall, in some measure, regulate the situation, when distributors sell medicinal products at prices, which exceed their declared level, because of excess of legislatively permitted speed of possible increasing of declared wholesale and selling price by rapid changes in exchange rate.
We are thrilled to announce a major milestone in our team's growth and celebrate the well-deserved career advancements of our colleagues.
Lexology Index: Employment & Labor highlights the leading legal specialists in the field from around the world.
On June 19, 2026, an event was held with the participation of businesses, regulators, and experts – titled “Regulatory Dialogue: The Cosmetics Market” – organiz
The event brought together leading industry experts for a comprehensive analysis of the institutional landscape and current legal challenges in the sphere of state-business interaction.
